These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 25615935)
1. Correction: Comparison of Clinical Manifestations and Outcomes between Hepatitis B Virus- and Hepatitis C Virus-Related Hepatocellular Carcinoma: Analysis of a Nationwide Cohort. PLOS ONE Staff PLoS One; 2015; 10(1):e0116652. PubMed ID: 25615935 [TBL] [Abstract][Full Text] [Related]
2. Correction: Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication. Motoyama H; Tamori A; Kubo S; Uchida-Kobayashi S; Takemura S; Tanaka S; Ohfuji S; Teranishi Y; Kozuka R; Kawamura E; Hagihara A; Morikawa H; Enomoto M; Murakami Y; Kawada N PLoS One; 2018; 13(7):e0201423. PubMed ID: 30040864 [TBL] [Abstract][Full Text] [Related]
3. Correction: Chronic Hepatitis C Virus Infection Is Associated with the Development of Rheumatoid Arthritis: A Nationwide Population-Based Study in Taiwan. Su FH; Wu CS; Sung FC; Chang SN; Su CT; Shieh YH; Yeh CC PLoS One; 2016; 11(11):e0166508. PubMed ID: 27829054 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study. Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774 [TBL] [Abstract][Full Text] [Related]
5. Characteristics of hepatocellular carcinoma in hemodialysis patients in hepatitis B endemic area. Tung CF; Yang DY; Hu WH; Peng YC; Chow WK; Chen GH Hepatogastroenterology; 2003; 50(53):1564-8. PubMed ID: 14571787 [TBL] [Abstract][Full Text] [Related]
6. Correction: the inhibitory effects of anacardic Acid on hepatitis C virus life cycle. PLOS ONE Staff PLoS One; 2015; 10(3):e0122379. PubMed ID: 25806528 [TBL] [Abstract][Full Text] [Related]
7. Viral pathogenesis of hepatocellular carcinoma in the United States. Liang TJ; Jeffers LJ; Reddy KR; De Medina M; Parker IT; Cheinquer H; Idrovo V; Rabassa A; Schiff ER Hepatology; 1993 Dec; 18(6):1326-33. PubMed ID: 8244256 [TBL] [Abstract][Full Text] [Related]
8. T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infection. Ito K; Tanaka Y; Orito E; Sugiyama M; Fujiwara K; Sugauchi F; Kato T; Tokita H; Izumi N; Kato M; Yuen MF; Lai CL; Gish RG; Ueda R; Mizokami M Clin Infect Dis; 2006 Jan; 42(1):1-7. PubMed ID: 16323084 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus core protein enhances human telomerase reverse transcriptase expression and hepatocellular carcinoma cell proliferation in a c-Ets2-dependent manner. Gai X; Zhao P; Pan Y; Shan H; Yue X; Du J; Zhang Z; Liu P; Ma H; Guo M; Yang X; Sun W; Gao L; Ma C; Liang X Int J Biochem Cell Biol; 2013 Jul; 45(7):1174-85. PubMed ID: 23542016 [TBL] [Abstract][Full Text] [Related]
10. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death. Chen JD; Yang HI; Iloeje UH; You SL; Lu SN; Wang LY; Su J; Sun CA; Liaw YF; Chen CJ; Gastroenterology; 2010 May; 138(5):1747-54. PubMed ID: 20114048 [TBL] [Abstract][Full Text] [Related]
11. Correction: Decreasing Hepatitis C Virus Infection in Thailand in the Past Decade: Evidence from the 2014 National Survey. Wasitthankasem R; Posuwan N; Vichaiwattana P; Theamboonlers A; Klinfueng S; Vuthitanachot V; Thanetkongtong N; Saelao S; Foonoi M; Fakthongyoo A; Makaroon J; Srisingh K; Asawarachun D; Owatanapanich S; Wutthiratkowit N; Tohtubtiang K; Yoocharoen P; Oota S; Vongpunsawad S; Poovorawan Y PLoS One; 2016; 11(5):e0152451. PubMed ID: 27191955 [TBL] [Abstract][Full Text] [Related]
12. A comparison of the surgical outcomes among patients with HBV-positive, HCV-positive, and non-B non-C hepatocellular carcinoma: a nationwide study of 11,950 patients. Utsunomiya T; Shimada M; Kudo M; Ichida T; Matsui O; Izumi N; Matsuyama Y; Sakamoto M; Nakashima O; Ku Y; Takayama T; Kokudo N; Ann Surg; 2015 Mar; 261(3):513-20. PubMed ID: 25072437 [TBL] [Abstract][Full Text] [Related]
13. [Clinical and etiologic features of hepatocarcinoma in Sicily]. Carroccio A; Soresi M; Bonfissuto G; Magliarisi C; Anastasi G; Vuturo O; Notarbartolo A; Montalto G Ann Ital Med Int; 1999; 14(4):233-8. PubMed ID: 10638015 [TBL] [Abstract][Full Text] [Related]
14. The role of chronic viral hepatitis in hepatocellular carcinoma in the United States. Di Bisceglie AM; Order SE; Klein JL; Waggoner JG; Sjogren MH; Kuo G; Houghton M; Choo QL; Hoofnagle JH Am J Gastroenterol; 1991 Mar; 86(3):335-8. PubMed ID: 1847790 [TBL] [Abstract][Full Text] [Related]
15. [The expression of hepatitis B virus X protein and cyclooxygenase-2 in hepatitis B virus-related hepatocellular carcinoma: correlation with microangiogenesis and metastasis, and what is the possible mechanism]. Liu KG; Shao XL; Xie HH; Xu L; Zhao H; Guo ZH; Li L; Liu J Zhonghua Gan Zang Bing Za Zhi; 2010 Nov; 18(11):831-6. PubMed ID: 21138631 [TBL] [Abstract][Full Text] [Related]
16. Correction: microRNA-122 Dependent Binding of Ago2 Protein to Hepatitis C Virus RNA Is Associated with Enhanced RNA Stability and Translation Stimulation. Conrad KD; Giering F; Erfurth C; Neumann A; Fehr C; Meister G; Niepmann M PLoS One; 2016; 11(7):e0160132. PubMed ID: 27472220 [TBL] [Abstract][Full Text] [Related]
17. Association of nucleos(t)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide cohort study. Wu CY; Lin JT; Ho HJ; Su CW; Lee TY; Wang SY; Wu C; Wu JC Gastroenterology; 2014 Jul; 147(1):143-151.e5. PubMed ID: 24704525 [TBL] [Abstract][Full Text] [Related]
18. Correction: Diabetes risks and outcomes in chronic obstructive pulmonary disease patients: Two nationwide population-based retrospective cohort studies. PLOS ONE Staff PLoS One; 2017; 12(12):e0190289. PubMed ID: 29261788 [TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and surgical outcome in hepatocellular carcinoma without hepatitis B virus surface antigen or hepatitis C virus antibody. Tanaka K; Shimada H; Matsuo K; Nagano Y; Endo I; Togo S Ann Surg Oncol; 2007 Mar; 14(3):1170-81. PubMed ID: 17195904 [TBL] [Abstract][Full Text] [Related]
20. General evaluation of hepatectomy and hepatocellular carcinoma cases. Başsüllü N; Türkmen I; Yaprak O; Dayangaç M; Demırbaş T; Güler N; Uraz S; Akyildiz M; Cığercıoğullari E; Tokat Y; Yüzer Y; Doğusoy GB Turk Patoloji Derg; 2011; 27(3):221-9. PubMed ID: 21935872 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]